Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.

Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.

Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.